whats a glp 1 drug GLP-1 Medications for Weight Loss New Guidelines on GLP-1 Drugs

These unfavorable adverse effects can pose obstacles to attaining optimal management of the blood glucose level [10, 11]

KFFs analysis of newly released Medicare Part D spending data from CMS shows that total gross Medicare spending on the three newest versions of these diabetes medications that have also been recently approved for weight loss Ozempic, Rybelsus, and Mounjaro has skyrocketed in recent years, rising from $57 million in 2018 to $5.7 billion in 2022 (Figure 1)

2024;16(11):e74345

The airball comes as Novo scrambles to regain a majority share of the GLP-1 market, which it lost to Lilly in recent months

However, the maximum recommended dose for Ozempic is 2 mg

Gastrointestinal tolerability may be challenging, as both ketogenic diets and GLP-1 agonists can cause nausea, constipation, and altered bowel habits